Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

计划入组 580 人 · 首次发布于 2020 年 9 月 24 日

Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

计划入组 6,600 人 · 首次发布于 2024 年 7 月 29 日

Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant

计划入组 66 人

Recombinant 9 Valent Human Papillomavirus Vaccine(Pichia)(Yidao Biotechnology)

Recombinant Human Papillomavirus Bivalent (Types 16,18) Vaccine(Escherichia coli)

Rx

Wichita State University

United States

ICHIM CRISTIAN

Italy

JICHI MEDICAL UNIVERSITY

Japan

Brazilian Researchers Identify Amazon Scorpion Venom Peptide with Promising Anti-Breast Cancer Activity

Researchers Achieve First-Ever Production of Human DNase1 in Yeast, Offering Cost-Effective Alternative to Hamster Cell Manufacturing

QIAGEN Expands QIAcuity Digital PCR Ecosystem with New Gene Expression Assays, High-Multiplex Capabilities, and Workflow Automation